Drug Shortage Report for RANITIDINE

Last updated on 2022-08-20 History
Report ID 94081
Drug Identification Number 02385961
Brand name RANITIDINE
Common or Proper name RANITIDINE
Company Name SIVEM PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-09-17
Actual start date 2019-09-17
Estimated end date Unknown
Actual end date 2022-08-19
Shortage status Resolved
Updated date 2022-08-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-08-20 English Compare
v5 2022-08-19 French Compare
v4 2022-08-19 English Compare
v3 2019-09-18 English Compare
v2 2019-09-17 French Compare
v1 2019-09-17 English Compare

Showing 1 to 6 of 6